MFDS
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇰🇷 Metixen in South Korea
Metixen (metixene) regulatory status in South Korea.
Marketing authorisation
Metixen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Metixen approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Metixen in South Korea?
NOVARTIS holds the South Korean marketing authorisation.